Ref.: BL-RE-143876Manufacturer ref.: EMMPOX5 5 x 96 tests
€2,950.00 excl. VAT
Kit ELISA Myeloperoxidase sandwich (mouse): quantitative assay of Ms Myeloperoxidase in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms Myeloperoxidase.
Accession number
P11247
Dose range
0.61 to 150 ng/ml
Sensitivity of the dosage
600 pg/ml
Calibration range
0.6 ng/ml to 150 ng/ml
Description
Kit ELISA for myeloperoxidase, 96 dosages, 1 kit, mouse species, HRP conjugate, colorimetric detection method, immuno-enzymatic assay for the quantification and detection of myeloperoxidase (MPO) in samples using a microplate reader
Brand
Invitrogen
Kit ELISA Myeloperoxidase sandwich (mouse): quantitative assay of Ms Myeloperoxidase in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms Myeloperoxidase.
Kit ELISA Myeloperoxidase sandwich (mouse): quantitative assay of Ms Myeloperoxidase in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms Myeloperoxidase.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Myeloperoxidase (MPO) is a hemoprotein that is expressed in abundance in neutrophils and secreted during activation. Native myeloperoxidase is represented as a covalently bound tetrameric complex of two alpha glycosylated chains with a molecular weight range of 59 - 64 kDa and two nonglycosylated beta chains (MW -14 kDa) with a total MW -150 kDa and a theoretical pI of 9.2. Traditionally, myeloperoxidase was considered the primary target of anti-neutrophilic cytoplasmic antibodies (ANCA), serological markers of certain systemic vasculities such as periarteriitis nodosa, microscopic polyarteriitis, and pulmonary eosinophilic granulomatosis (Churg-Strauss syndrome). Low to moderate levels of auto-anti-myeloperoxidase antibodies are also reported in rheumatoid arthritis. Recently, myeloperoxidase has been shown to be involved in the initiation and progression of cardiovascular disease. Myeloperoxidase has powerful pro-inflammatory properties and can directly contribute to tissue damage. Myeloperoxidase is now considered one of the most promising cardiac markers. Myeloperoxidase is part of the polymorphonuclear leukocyte host defense system and myeloperoxidase is responsible for microbicide activity against a wide range of organisms. In stimulated PMN (polymorphonuclear leukocytes), MPO catalyzes the production of hypohalous acids, mainly hypochlorous acid in physiological situations and other toxic intermediates that significantly improve the microbicide activity of PMN.
Sensitivity
Sensitivity of dosage: 600 pg/ml.
Measurement range
Dose range: 0.61 to 150 ng/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This pair of ELISA antibodies detects mouse MPO. Other species not yet determined.
Kit ELISA for myeloperoxidase, 96 dosages, 1 kit, mouse species, HRP conjugate, colorimetric detection method, immuno-enzymatic assay for the quantification and detection of myeloperoxidase (MPO) in samples using a microplate reader